Fabrizio, M C <br/><br/>
Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.  [electronic resource] 

 -  The journal of extra-corporeal technology  May 2001 
 - 117-25 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0022-1058 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--adverse effects<br/>Blood Coagulation Tests<br/>Cardiopulmonary Bypass<br/>Endopeptidases--blood<br/>Heparin--adverse effects<br/>Hirudin Therapy<br/>Hirudins--analogs & derivatives<br/>Humans<br/>Male<br/>Middle Aged<br/>Pennsylvania<br/>Recombinant Proteins--therapeutic use<br/>Thrombocytopenia--chemically induced